IP Library › Granted Patent US 11,450,235
Granted Patent B2
US 11,450,235 · App. 15/736,347 · Granted Sep 20, 2022

Devices and methods for drug administration and mixing, and training of proper techniques therefor

Inventors: Peter A. Krulevitch (Pleasanton, CA); Ian Scrimgeour (Dunbar, GB); Scott Martin (Edinburgh, GB); James McLusky (Edinburgh, GB); James Glencross (Edinburgh, GB); Blair Hutton (Edinburgh, GB); Nick Foley (Edinburgh, GB); Jose Antonio Buron Vidal (Parede, PT)
Assignee: Janssen Pharmaceutica N.V.
G09B23/28A61J1/16A61J1/2055A61J1/2096A61J7/0053A61M5/1782G09B5/02G09B23/285A61J2200/70A61M2205/50A61M2205/581
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,450,235
App. No.
15/736,347
Granted
Sep 20, 2022
Kind
B2
Abstract

A device for training users in a proper mixing of pharmaceutical components, or for aiding in the mixing, or for performing the mixing, and administration of pharmaceutical components is disclosed. The device comprises a housing for receiving a pharmaceutical delivery device containing the pharmaceutical components. There is also a microcontroller disposed in the housing and a motion/orientation detection device disposed within or on the housing and in communication with the microcontroller. A method for use of the device is also disclosed, along with a substance for use as one of the pharmaceutical components.

Claims (21)

1. An assistive device for training or aiding users in a proper mixing of pharmaceutical components, comprising:

a housing including a syringe clamping slot having a syringe retaining clip attached thereto, the syringe clamping slot adapted to receive a barrel of a syringe that contains pharmaceutical components, the syringe retaining clip adapted to directly engage and retain the barrel of the syringe in the syringe clamping slot;

a microcontroller disposed in the housing; and

a motion/orientation detection device disposed in the housing and electrically connected to the microcontroller whereby the microcontroller is configured to detect a motion and/or orientation of the housing to train or aid users in the proper mixing of pharmaceutical components.

2. The device of claim 1 , wherein the housing defines a longitudinal axis.

3. The device of claim 2 , wherein the housing defines a major longitudinal axis.

4. The device of claim 2 , wherein the syringe clamping slot is adapted to receive a syringe having a major longitudinal axis, and further to align the longitudinal axis of the housing along the major longitudinal axis of the syringe.

5. The device of claim 1 , further comprising a user notification device.

6. The device of claim 1 , wherein the microcontroller is configured to detect whether the motion or orientation of the housing being shaken during one of a pharmaceutical administration or a training event is sufficient with respect to predetermined thresholds including one or more of: magnitude of the force applied during the shaking, the orientation of the housing and duration of such shaking.

7. The device of claim 1 , further comprising a user notification device, wherein the microcontroller is configured to notify a user via the user notification device as to whether the motion or orientation of the housing being shaken during one of a drug administration or a training event is sufficient with respect to predetermined thresholds including one or more of: magnitude of the force applied during the shaking, the orientation of the housing and duration of such shaking.

8. The device of claim 1 , further comprising a power source disposed in or on the housing.

9. The device of claim 8 , wherein the power source is connected to the microcontroller for powering the microcontroller and/or a user notification device.

10. The device of claim 1 , wherein the housing comprises an opening through which at least a portion of the syringe barrel can extend.

11. The device of claim 1 , wherein the housing comprises a puck-like body.

12. The device of claim 1 , wherein the housing is adapted to fit around only a portion of the barrel of the syringe.

13. The device of claim 1 , wherein the motion/orientation detection device is an accelerometer.

14. The device of claim 1 , wherein the pharmaceutical components comprise at least two phases.

15. The device of claim 14 , wherein at least one of the two phases is a solid phase and at least one of the two phases is a liquid phase.

16. The device of claim 14 , wherein two of the at least two phases are liquid phases.

17. The device of claim 1 , wherein the housing comprises a portion adapted to engage a syringe back stop of the syringe.

18. The device of claim 1 , wherein the syringe includes a plunger that is manually depressible by a user.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2021
From: KRULEVITCH, PETER; SCRIMGEOUR, IAN; MARTIN, SCOTT; MCLUSKY, JAMES; GLENCROSS, JAMES; HUTTON, BLAIR; FOLEY, NICK; BURON VIDAL, JOSE ANTONIO
To: JANSSEN PHARMACEUTICA NV
Reel/Frame 055931/0001 →
Continuity (2)
Provisional Application 62182426 · Jun 19, 2015
Related Publication 20180190154A1 · Jul 5, 2018